Euclidean Technologies Management, LLC Viatris Inc Transaction History
Euclidean Technologies Management, LLC
- $109 Million
- Q1 2023
A detailed history of Euclidean Technologies Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Euclidean Technologies Management, LLC holds 15,666 shares of VTRS stock, worth $200,994. This represents 0.14% of its overall portfolio holdings.
Number of Shares
15,666
Previous 15,666
-0.0%
Holding current value
$200,994
Previous $174,000
13.79%
% of portfolio
0.14%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,102Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.81 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.19 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$810 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$804 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$626 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...